Diagnostic value of tumor antigens in malignant pleural effusion

A meta-analysis

Austin H. Nguyen, Elliott J. Miller, Christopher S. Wichman, Ilya Berim, Devendra K. Agrawal

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The diagnostic value of tumor markers, carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9, CA 125, cytokeratin fragment (CYFRA), and neuron-specific enolase (NSE) in pleural fluid to differentiate between benign and malignant pleural effusion (MPE) has not yet been clearly established. A review of English language studies using human subjects was performed. Sensitivity and specificity values of the chosen tumor markers were pooled using a random effects model to generate hierarchical summary receiver operator curves to determine the diagnostic performance of each tumor marker. A total of 49 studies were included in the final analysis. Pooled sensitivity and specificity values for chosen tumor markers for diagnosing MPE are as follows: CEA, 0.549 and 0.962; CA 15-3, 0.507 and 0.983; CA 19-9, 0.376 and 0.980; CA 125, 0.575 and 0.928; CYFRA, 0.625 and 0.932; NSE, 0.613 and 0.884. The use of individual tumor markers in diagnosing MPE has many benefits (cost, invasiveness, and so forth). Although these tumor markers exhibit high specificity, the low sensitivity of each marker limits the diagnostic value. We conclude that tumor markers used individually are of insufficient diagnostic accuracy for clinical use. Tumor markers used in various combinations or from serum may have some potential worth further investigation.

Original languageEnglish
Pages (from-to)432-439
Number of pages8
JournalTranslational Research
Volume166
Issue number5
DOIs
StatePublished - Nov 1 2015

Fingerprint

Malignant Pleural Effusion
Neoplasm Antigens
Tumor Biomarkers
Meta-Analysis
Antigens
Neoplasms
Phosphopyruvate Hydratase
Carcinoembryonic Antigen
Keratins
Sensitivity and Specificity
Differentiation Antigens
Cost-Benefit Analysis
Language
Fluids

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, medical
  • Public Health, Environmental and Occupational Health

Cite this

Diagnostic value of tumor antigens in malignant pleural effusion : A meta-analysis. / Nguyen, Austin H.; Miller, Elliott J.; Wichman, Christopher S.; Berim, Ilya; Agrawal, Devendra K.

In: Translational Research, Vol. 166, No. 5, 01.11.2015, p. 432-439.

Research output: Contribution to journalArticle

Nguyen, Austin H. ; Miller, Elliott J. ; Wichman, Christopher S. ; Berim, Ilya ; Agrawal, Devendra K. / Diagnostic value of tumor antigens in malignant pleural effusion : A meta-analysis. In: Translational Research. 2015 ; Vol. 166, No. 5. pp. 432-439.
@article{b831ec443c7f4049b27b3dfbfc1a1ce9,
title = "Diagnostic value of tumor antigens in malignant pleural effusion: A meta-analysis",
abstract = "The diagnostic value of tumor markers, carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9, CA 125, cytokeratin fragment (CYFRA), and neuron-specific enolase (NSE) in pleural fluid to differentiate between benign and malignant pleural effusion (MPE) has not yet been clearly established. A review of English language studies using human subjects was performed. Sensitivity and specificity values of the chosen tumor markers were pooled using a random effects model to generate hierarchical summary receiver operator curves to determine the diagnostic performance of each tumor marker. A total of 49 studies were included in the final analysis. Pooled sensitivity and specificity values for chosen tumor markers for diagnosing MPE are as follows: CEA, 0.549 and 0.962; CA 15-3, 0.507 and 0.983; CA 19-9, 0.376 and 0.980; CA 125, 0.575 and 0.928; CYFRA, 0.625 and 0.932; NSE, 0.613 and 0.884. The use of individual tumor markers in diagnosing MPE has many benefits (cost, invasiveness, and so forth). Although these tumor markers exhibit high specificity, the low sensitivity of each marker limits the diagnostic value. We conclude that tumor markers used individually are of insufficient diagnostic accuracy for clinical use. Tumor markers used in various combinations or from serum may have some potential worth further investigation.",
author = "Nguyen, {Austin H.} and Miller, {Elliott J.} and Wichman, {Christopher S.} and Ilya Berim and Agrawal, {Devendra K.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.trsl.2015.04.006",
language = "English",
volume = "166",
pages = "432--439",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Diagnostic value of tumor antigens in malignant pleural effusion

T2 - A meta-analysis

AU - Nguyen, Austin H.

AU - Miller, Elliott J.

AU - Wichman, Christopher S.

AU - Berim, Ilya

AU - Agrawal, Devendra K.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The diagnostic value of tumor markers, carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9, CA 125, cytokeratin fragment (CYFRA), and neuron-specific enolase (NSE) in pleural fluid to differentiate between benign and malignant pleural effusion (MPE) has not yet been clearly established. A review of English language studies using human subjects was performed. Sensitivity and specificity values of the chosen tumor markers were pooled using a random effects model to generate hierarchical summary receiver operator curves to determine the diagnostic performance of each tumor marker. A total of 49 studies were included in the final analysis. Pooled sensitivity and specificity values for chosen tumor markers for diagnosing MPE are as follows: CEA, 0.549 and 0.962; CA 15-3, 0.507 and 0.983; CA 19-9, 0.376 and 0.980; CA 125, 0.575 and 0.928; CYFRA, 0.625 and 0.932; NSE, 0.613 and 0.884. The use of individual tumor markers in diagnosing MPE has many benefits (cost, invasiveness, and so forth). Although these tumor markers exhibit high specificity, the low sensitivity of each marker limits the diagnostic value. We conclude that tumor markers used individually are of insufficient diagnostic accuracy for clinical use. Tumor markers used in various combinations or from serum may have some potential worth further investigation.

AB - The diagnostic value of tumor markers, carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9, CA 125, cytokeratin fragment (CYFRA), and neuron-specific enolase (NSE) in pleural fluid to differentiate between benign and malignant pleural effusion (MPE) has not yet been clearly established. A review of English language studies using human subjects was performed. Sensitivity and specificity values of the chosen tumor markers were pooled using a random effects model to generate hierarchical summary receiver operator curves to determine the diagnostic performance of each tumor marker. A total of 49 studies were included in the final analysis. Pooled sensitivity and specificity values for chosen tumor markers for diagnosing MPE are as follows: CEA, 0.549 and 0.962; CA 15-3, 0.507 and 0.983; CA 19-9, 0.376 and 0.980; CA 125, 0.575 and 0.928; CYFRA, 0.625 and 0.932; NSE, 0.613 and 0.884. The use of individual tumor markers in diagnosing MPE has many benefits (cost, invasiveness, and so forth). Although these tumor markers exhibit high specificity, the low sensitivity of each marker limits the diagnostic value. We conclude that tumor markers used individually are of insufficient diagnostic accuracy for clinical use. Tumor markers used in various combinations or from serum may have some potential worth further investigation.

UR - http://www.scopus.com/inward/record.url?scp=84944277630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944277630&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2015.04.006

DO - 10.1016/j.trsl.2015.04.006

M3 - Article

VL - 166

SP - 432

EP - 439

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 5

ER -